Clinical benefits of biochemical markers of bone turnover in Egyptian children with chronic liver diseases

World Journal of Gastroenterology

Volumn 13, Issue 5, 2007, Pages 785-790

  Mahdy, Karam A ^a   Ahmed, Hanaa H ^a   Mannaa, Fathia ^a   Abdel Shaheed, Azza ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Bone turnover; Insulin like growth factor 1; Liver disease; Osteo0calcin; Parathyroid hormone

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B CORE ANTIBODY; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; OSTEOCALCIN; PARASITE ANTIBODY; PARATHYROID HORMONE; PLASMA PROTEIN; SOMATOMEDIN C; VIRUS RNA;

ADOLESCENT; ARTICLE; BONE REMODELING; BONE TURNOVER; CHILD; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION TEST; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHISTOSOMIASIS;

EID: 33846947967     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i5.785     Document Type: Article

References (40)

1. Seibel MJ, Bone metabolism, mineral homeostasis and its pharmacological modulation. Clin Lab 2004; 50: 255-264
2. Iber F. Bone disease in chronic liver disease. Am J Gastroenterol 1989; 84: 1229-1230
3. Rabinovitz M, Shapiro J, Lian J, Block GD, Merkel IS, Van Thiel DH. Vitamin D and osteocalcin levels in liver transplant recipients. Is osteocalcin a reliable marker of bone turnover in such cases? J Hepatol 1992; 16: 50-55
4. Ravn P, Fledelius C, Rosenquist C, Overgaard K, Christiansen C. High bone turnover is associated with low bone mass in both pre- and postmenopausal women. Bone 1996; 19: 291-298
5. Guanabens N, Pares A, Marinoso L, Brancos MA, Piera C, Serrano S, Rivera F, Rodes J. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol 1990; 85: 1356-1362
6. Bonkovsky HL, Hawkins M, Steinberg K, Hersh T, Galambos JT, Henderson JM, Millikan WJ, Galloway JR. Prevalence and prediction of osteopenia in chronic liver disease. Hepatology 1990; 12: 273-280
7. Compston JE. Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut 1986; 27: 1073-1090
8. Wu YL, Ye J, Zhang S, Zhong J, Xi RP. Clinical significance of serum IGF-I, IGF-II and IGTBP-3 in liver cirrhosis. World J Gastroenterol 2004; 10: 2740-2743
9. Delmas PD, Wahner HW, Mann KG, Riggs BL. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. J Lab Clin Med 1983; 102: 470-476
10. Boniolo A, Dovis M, Matteja R. Use of an enzyme-linked immunosorbent assay for screening hybridoma antibodies against hepatitis B surface antigen. J Immunol Methods 1982; 49: 1-15
11. Tedder RS, Wilson-Croome R. IgM-antibody response to the hepatitis B core antigen in acute and chronic hepatitis B. J Hyg (Lond) 1981; 86: 163-172
12. Hoofnagle JH, Gerety RJ, Barker LF. Antibody to hepatitis-B-virus core in man. Lancet 1973; 2: 869-873
13. Alter HJ, Prince AM. Transfusion-associated non-A, non-B hepatitis: an assessment of the causative agent and its clinical impact. Transfus Med Rev 1988; 2: 288-293
14. Ravaggi A, Primi D, Cariani E. Direct PCR amplification of HCV RNA from human serum. PCR Methods Appl 1992; 1: 291-292
15. Hoshino S, Camargo ME, da Silva LC. Standardization of a hemagglutination test for schistosomiasis with formalin-treated human erythrocytes. Am J Trop Med Hyg 1970; 19: 463-470
16. Poller L. Laboratory control of anticoagulant therapy. Semin Thromb Hemost 1986; 12: 13-19
17. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB. Serum levels of insulin-like growth factor I (IGF-1) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 1993; 76: 1610-1616
18. Coleman RE, Mashiter G, Fogelman I, Whitaker KD, Caleffi M, Moss DW, Rubens RD. Osteocalcin: a potential marker of metastatic bone disease and response to treatment. Eur J Cancer Clin Oncol 1988; 24: 1211-1217
19. Goltzman D, Henderson B, Loveridge N. Cytochemical bioassay of parathyroid hormone: characteristics of the assay and analysis of circulating hormonal forms. J Clin Invest 1980; 65: 1309-1317
20. Snedecor GW, Cochran WG. Statistical Methods, 7th ed. Ames, Iowa: The Iowa State University Press, 1980
21. Walter A, Duncan DB. Multiple range and multiple test. Biometrics 1969; 11: 1-24
22. Sherlock S, Dooley J. Cholestatis. In: Diseases of the liver and biliary system.10th ed., Sherlock S, Dooley J (eds), Blackwell Scientific Publications, 1997: 217-273
23. Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, Wiese M, Moessner J. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 2005; 11: 1843-1847
24. Hassan AH, Abd el Moneim MA, Abd el Aal AA, Abou Aly SA, Ahmed SH, Soliman AT, el Kersh MM. Circulating growth hormone, insulin-like growth factor I, cortisol and free thyroxine in children with schistosomiasis with and without hepatic fibrosis. J Trop Pediatr 1991; 37: 25-30
25. Orsini M, Rocha RS, Disch J, Katz N, Rabello A. The role of nutritional status and insulin-like growth factor in reduced physical growth in hepatosplenic Schistosoma mansoni infection. Trans R Soc Trop Med Hyg 2001; 95: 453-456
26. Mazziotti G, Sorvillo F, Morisco F, Carbone A, Rotondi M, Stornaiuolo G, Precone DF, Cioffi M, Gaeta GB, Caporaso N, Carella C. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. Cancer 2002; 95: 2539-2545
27. Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998; 28: 695-699
28. Chui SH, Chan K, Chui AK, Shek LS, Wong RN. The effects of a Chinese medicinal suppository (Vitalliver) on insulin-like growth factor 1 and homocysteine in patients with hepatitis B infection. Phytother Res 2005; 19: 674-678
29. Suzuki K, Arakawa Y, Chino S, Yagi K. Hepatic osteodystrophy. Nippon Rinsho 1998; 56: 1604-1608
30. Resch H, Pietschmann P, Krexner E, Woloszczuk W, Willvonseder R. Peripheral bone mineral content in patients with fatty liver and hepatic cirrhosis. Scand J Gastroenterol 1990; 25: 412-416
31. Crosbie OM, Freaney R, McKenna MJ, Hegarty JE. Bone density, vitamin D status, and disordered bone remodeling in end-stage chronic liver disease. Calcif Tissue Int 1999; 64: 295-300
32. Fonseca V, Epstein O, Gill DS, Menon RK, Thomas M, McIntyre N, Dandona P. Hyperparathyroidism and low serum osteocalcin despite vitamin D replacement in primary biliary cirrhosis. J Clin Endocrinol Metab 1987; 64: 873-877
33. Kirch W, Hofig M, Ledendecker T, Schmidt-Gayk H. Parathyroid hormone and cirrhosis of the liver. J Clin Endocrinol Metab 1990; 71: 1561-1566
34. Wiczkowski A. The influence of hypervolemia on the secretion of atrial natriuretic peptide, the renin-angiotensin-aldosterone system's activity and concentration of vasopressin, parathormone and calcitonin in hepatitis B virus infected patients with chronic liver diseases. Przegl Epidemiol 1994; 48: 433-440
35. Fradkin JM, Braniecki AM, Craig TM, Ramiro-Ibanez F, Rogers KS, Zoran DL. Elevated parathyroid hormone-related protein and hypercalcemia in two dogs with schistosomiasis. J Am Anim Hosp Assoc 2001; 37: 349-355
36. Mehany NL, Mostafa AA, El-karaksy H, El-Asrag HA and El-Bayoumy AS. Vitamin D metabolism and related biochemical parameters in children with chronic liver diseases. Arab J Lab Med 2000; 26: 331-348
37. Duarte MP, Farias ML, Coelho HS, Mendonca LM, Stabnov LM, do Carmo d Oliveira M, Lamy RA, Oliveira DS. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 2001; 16: 1022-1027
38. Karan MA, Erten N, Tascioglu C, Karan A, Sindel D, Dilsen G. Osteodystrophy in posthepatitic cirrhosis. Yonsei Med J 2001; 42: 547-552
39. Nakano A, Kanda T, Abe H. Bone changes and mineral metabolism disorders in rats with experimental liver cirrhosis. J Gastroenterol Hepatol 1996; 11: 1143-1154
40. Steinberg KK, Bonkovsky HL, Caudill SP, Bernhardt RK, Hawkins M. Osteocalcin and bone alkaline phosphatase in the serum of women with liver disease. Ann Clin Lab Sci 1991; 21: 305-314